Inflammation as a central mechanism in Alzheimer's disease

Kinney, Jefferson W., Bemiller, Shane M., Murtishaw, Andrew S., Leisgang, Amanda M., Salazar, Arnold M., Lamb, Bruce T.·2018·Alzheimer's & Dementia: Translational Research & Clinical Interventions

Cited by (1,008)

Items 501–600 of 1,008

  1. Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease
    Eunshil Lee, Yongmin Chang · 2025 · Cells
  2. Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
    Knut Biber, Anindya Bhattacharya, Brian M. Campbell, Justin R. Piro, Michael Rohe, Roland G. W. Staal, Robert V. Talanian, Thomas Möller · 2019 · Frontiers in Pharmacology
  3. Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease
    Kang, You Jung, Diep, Yen N., Tran, Minh, Cho, Hansang · 2020 · International Journal of Molecular Sciences
  4. Cognitive and Physical Intervention in Metals’ Dysfunction and Neurodegeneration
    Anna Jopowicz, Justyna Wiśniowska, Beata Tarnacka · 2022 · Brain Sciences
  5. AAV‐mediated expression of secreted and transmembrane αKlotho isoforms rescues relevant aging hallmarks in senescent SAMP8 mice
    Joan Roig-Soriano, Christian Griñán‐Ferré, Juan F. Espinosa‐Parrilla, Carmela R. Abraham, Assumpció Bosch, Mercè Pallàs, Miguel Chillón · 2022 · Aging Cell
  6. Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease
    Richard Lathe, Nikki M Schultek, Brian Joseph Balin, Garth D. Ehrlich, Lavinia Auber Alberi, George L. Perry, Edward Bealmear Breitschwerdt, David Brian Corry, Richard L. Doty, Robert A. Rissman et al. · 2023 · Alzheimer s & Dementia
  7. Gene networks and systems biology in Alzheimer's disease: Insights from multi‐omics approaches
    Negin Rahimzadeh, Shushrruth Sai Srinivasan, Jing Zhang, Vivek Swarup · 2024 · Alzheimer s & Dementia
  8. Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model
    Minmin Yao, Zhiliang Wei, Jonathan Scharff Nielsen, Yuxiao Ouyang, Aaron Kakazu, Haitong Wang, Lida Du, Ruoxuan Li, Tiffany Chu, Susanna Scafidi et al. · 2024 · Neurobiology of Disease
  9. Role of the transcription factor NRF2 in maintaining the integrity of the Blood-Brain Barrier
    Eduardo Cazalla, Antonio Cuadrado, Ángel J. García‐Yagüe · 2024 · Fluids and Barriers of the CNS
  10. Alzheimer's disease mechanisms in peripheral cells: Promises and challenges
    Eugenia V. Trushina · 2019 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  11. The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention
    Sara Merlo, Simona Federica Spampinato, Grazia Ilaria Caruso, Maria Angela Sortino · 2020 · Current Neuropharmacology
  12. Mild Cognitive Impairment Patients Have Higher Regulatory T-Cell Proportions Compared With Alzheimer's Disease-Related Dementia Patients
    Jiping Fu, Jinhai Duan, Jianwei Mo, Hao Xiao, Yuedong Huang, Weiping Chen, Shaotong Xiang, Fan Yang, Yongjun Chen, Shuwen Xu · 2021 · Frontiers in Aging Neuroscience
  13. 24(S)-Saringosterol Prevents Cognitive Decline in a Mouse Model for Alzheimer’s Disease
    Nikita Martens, Melissa Schepers, Na Zhan, Frank P. J. Leijten, Gardi J. Voortman, Assia Tiane, Ben Rombaut, Janne Poisquet, Nienke van de Sande, Anja Kerksiek et al. · 2021 · Marine Drugs
  14. Astrocytes in Down Syndrome Across the Lifespan
    Ponroy Bally, Blandine, Murai, Keith K. · 2021 · Frontiers in Cellular Neuroscience
  15. Integrative Network-Based Analysis Reveals Gene Networks and Novel Drug Repositioning Candidates for Alzheimer Disease
    Zachary F. Gerring, Eric R. Gamazon, Anthony Robert White, Eske M. Derks · 2021 · Neurology Genetics
  16. Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective
    Rajashree Banerjee, Arushi Rai, Shreyas Iyer, Sonia Narwal, Meghana Tare · 2022 · Animal Models and Experimental Medicine
  17. Diabetic patients treated with metformin during early stages of Alzheimer’s disease show a better integral performance: data from ADNI study
    Carlos Javier Pomilio, Nicolás González Pérez, Ismael Luis Calandri, Lucía Crivelli, Ricardo Allegri, The ADNI Alzheimer’s Disease Neuroimaging Initiative, Gustavo Emilio Sevlever, Flavia Saravia · 2022 · GeroScience
  18. Chemical Composition and Potential Properties in Mental Illness (Anxiety, Depression and Insomnia) of Agarwood Essential Oil: A Review
    Xiqin Chen, Canhong Wang, Qingqin He, Jian Feng, De-Li Chen, Jianhe Wei, Yangyang Liu · 2022 · Molecules
  19. Sleep disturbance is associated with mild cognitive impairment: a community population-based cross-sectional study
    Fan Gao, Shan Wei, Liangjun Dang, Yao Gao, Ling Gao, Suhang Shang, Chen Chen, Kang Huo, Jingyi Wang, Jin Wang et al. · 2022 · BMC Public Health
  20. Mid‐life leukocyte telomere length and dementia risk: An observational and mendelian randomization study of 435,046 UK Biobank participants
    Liu, Rui, Xiang, Meiruo, Pilling, Luke C., Melzer, David, Wang, Lihong, Manning, Kevin J., Steffens, David C., Bowden, Jack, Fortinsky, Richard H., Kuchel, George A. et al. · 2023 · Aging Cell
  21. Ameliorative effect of deoxyvasicine on scopolamine-induced cognitive dysfunction by restoration of cholinergic function in mice
    Deng, Gang, Wu, Chao, Rong, Xiaojuan, Li, Shuping, Ju, Zhengcai, Wang, Youxu, Ma, Chao, Ding, Wenzheng, Guan, Huida, Cheng, Xuemei et al. · 2019 · Phytomedicine
  22. RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome
    Hamlett, Eric D., Hjorth, Erik, Ledreux, Aurélie, Gilmore, Anah, Schultzberg, Marianne, Granholm, Ann Charlotte · 2020 · Glia
  23. LC-MS/MS Isomeric Profiling of N-Glycans Derived from Low-Abundant Serum Glycoproteins in Mild Cognitive Impairment Patients
    Cristian D. Gutierrez Reyes, Md Abdul Hakim, Mojgan Atashi, Mona Goli, Sakshi Gautam, Junyao Wang, Andrew I. Bennett, Jianhui Zhu, David M. Lubman, Yehia S. Mechref · 2022 · Biomolecules
  24. The Contribution of the Locus Coeruleus–Noradrenaline System Degeneration during the Progression of Alzheimer’s Disease
    Dilek Mercan, Michael Thomas Heneka · 2022 · Biology
  25. Urolithin A exhibits a neuroprotective effect against Alzheimer’s disease by inhibiting DYRK1A activity
    Huang‐Ju Tu, C SU, Chao-Shiang Peng, Tony Eight Lin, Wei-Chun Huang Fu, Kai‐Cheng Hsu, Tsong‐Long Hwang, Shiow‐Lin Pan · 2023 · Journal of Food and Drug Analysis
  26. CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
    Francis Shue, Launia J. White, Rachel D. Hendrix, Jason D. Ulrich, Rachel L. Henson, William Knight, Yuka A. Martens, Ni Wang, Bhaskar Roy, Skylar C Starling et al. · 2024 · Science Advances
  27. Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders
    Irina S. Balan, Giorgia Boero, Samantha Lucenell Chéry, Minna H. McFarland, Alejandro G. Lopez, A. Leslie Morrow · 2024 · Life
  28. A serum protein signature of APOE genotypes in centenarians
    Paola Sebastiani, Stefano Monti, Melody K. Morris, Anastasia Gurinovich, Toshiko Tanaka, Stacy L. Andersen, Benjamin Sweigart, Luigi Ferrucci, Lori L. Jennings, David J. Glass et al. · 2019 · Aging Cell
  29. Peripheral cytokine and fatty acid associations with neuroinflammation in AD and aMCI patients: An exploratory study
    Giulia Cisbani, Alex Koppel, Dunja Knezevic, Ivonne Suridjan, Romina Mizrahi, Richard Paul Bazinet · 2020 · Brain Behavior and Immunity
  30. Molecular mechanisms underlying actions of certain long noncoding RNAs in Alzheimer’s disease
    Shamseddin Ahmadi, Mohammad Zobeiri, Steven Bradburn · 2020 · Metabolic Brain Disease
  31. Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammation
    Alistair L. Carr, Anniek J. Sluiman, Sheila M. Grecian, Rachel Forster, Stela McLachlan, Mark W. J. Strachan, Jackie F. Price · 2020 · Diabetologia
  32. Nutraceutical and therapeutic potential of Phycocyanobilin for treating Alzheimer’s disease
    Beatriz Piniella‐Matamoros, Javier Marín‐Prida, Giselle Pentón‐Rol · 2021 · Journal of Biosciences
  33. Repetitive transcranial magnetic stimulation (rTMS) for multiple neurological conditions in rodent animal models: A systematic review
    Xuemei Zong, Jie Gu, Deqin Geng, Dianshuai Gao · 2022 · Neurochemistry International
  34. Long Non-Coding RNAs, Extracellular Vesicles and Inflammation in Alzheimer’s Disease
    Ania Canseco-Rodríguez, Valeria Masola, Vincenza Aliperti, María Meseguer-Beltrán, Aldo Donizetti, Ana María Sánchez‐Pérez · 2022 · International Journal of Molecular Sciences
  35. Multiregion transcriptomic profiling of the primate brain reveals signatures of aging and the social environment
    Kenneth L. Chiou, Alex R. DeCasien, Katherina P. Rees, Camille Testard, Cailyn H. Spurrell, Aishwarya A. Gogate, Hannah A. Pliner, Sébastien Tremblay, Arianne Mercer, Connor J. Whalen et al. · 2022 · Nature Neuroscience
  36. Insights into the Pathophysiology of Alzheimer’s Disease and Potential Therapeutic Targets: A Current Perspective
    Kesevan Rajah Kumaran, Suleiman Yunusa, Enoch Kumar Perimal, Habibah A. Wahab, Christian P. Müller, Zurina Hassan · 2022 · Journal of Alzheimer s Disease
  37. Programmed ageing: decline of stem cell renewal, immunosenescence, and Alzheimer's disease
    Richard Lathe, David St Clair · 2023 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
  38. MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
    Ivana Raffaele, Serena Silvestro, Emanuela Mazzon · 2023 · International Journal of Molecular Sciences
  39. Lantana camara leaf extract ameliorates memory deficit and the neuroinflammation associated with scopolamine-induced Alzheimer’s-like cognitive impairment in zebrafish and mice
    Veronica Amoah, Paul Atawuchugi, Jibira Yakubu, Augustine Tandoh, Paul Poku Sampene Ossei, George Henry Sam ., George K. Ainooson · 2023 · Pharmaceutical Biology
  40. Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease
    Chang F. Qu, Qingqing Xu, Wen Yang, Mei Zhong, Qiuju Yuan, Yan‐Fang Xian, Zhi‐Xiu Lin · 2023 · Journal of Pharmaceutical Analysis
  41. NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders
    Yuri Zilberter, Dennis R. Tabuena, Misha Y. Zilberter · 2023 · Progress in Neurobiology
  42. Existing and Future Strategies to Manipulate the Gut Microbiota With Diet as a Potential Adjuvant Treatment for Psychiatric Disorders
    Fiona C. Ross, D.E. Mayer, Arpana Gupta, Chris I. R. Gill, Daniele Del Rio, John F. Cryan, Aonghus Lavelle, R. Paul Ross, Catherine Stanton, Emeran A. Mayer · 2023 · Biological Psychiatry
  43. Pomegranate (Punica granatum L.) Extract Effects on Inflammaging
    Raffaele Cordiano, Luca Gammeri, Eleonora Di Salvo, Sebastiano Gangemi, Paola Lucia Minciullo · 2024 · Molecules
  44. Alzheimers Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease
    Cinzia Severini, Christian Barbato, Maria Grazia Di Certo, Francesca Gabanella, Carla Petrella, Arianna Di Stadio, Marco DE VINCENTIIS, Antonella Polimeni, Massimo Ralli, Antonio Greco · 2020 · Current Neuropharmacology
  45. Longitudinal retinal layer changes in preclinical Alzheimer’s disease
    Jacoba A. van de Kreeke, Hoang Ton Nguyen, Elles Konijnenberg, Jori Tomassen, Anouk den Braber, Mara ten Kate, Maqsood M. Yaqub, Bart N.M. van Berckel, Adriaan A. Lammertsma, Dorret Irene Boomsma et al. · 2020 · Acta Ophthalmologica
  46. Amyloids: The History of Toxicity and Functionality
    Elmira I. Yakupova, Liya G. Bobyleva, Sergey A. Shumeyko, Ivan M. Vikhlyantsev, A. G. Bobylev · 2021 · Biology
  47. Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
    Heeyoung Kang, Hyun Joo Shin, Hyeong Seok An, Zhen Hua Jin, Jong Youl Lee, Jaewoong Lee, Kyung Eun Kim, Eun Ae Jeong, Kyu Yeong Choi, Catriona McLean et al. · 2021 · Antioxidants
  48. The beneficial effect of synbiotics consumption on Alzheimer's disease mouse model via reducing local and systemic inflammation
    Shin-Meng Deng, Chia-Jung Chen, Hung-Lung Lin, I. Cheng · 2021 · IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology
  49. Presenilin 2 N141I mutation induces hyperactive immune response through the epigenetic repression of REV-ERBα
    Hyeri Nam, Younghwan Lee, Boil Kim, Ji-Won Lee, Seohyeon Hwang, Hyun‐Kyu An, Kyung Min Chung, Young‐Jin Park, Jihyun Hong, Kyungjin Kim et al. · 2022 · Nature Communications
  50. Nattokinase attenuates bisphenol A or gamma irradiation-mediated hepatic and neural toxicity by activation of Nrf2 and suppression of inflammatory mediators in rats
    Mustafa M. M. Elbakry, Somaya Zakaria Mansour, Hamed Helal, Esraa S. A. Ahmed · 2022 · Environmental Science and Pollution Research
  51. Laminin as a Biomarker of Blood–Brain Barrier Disruption under Neuroinflammation: A Systematic Review
    Juan Felipe Zapata-Acevedo, Valentina Garcia Perez, Ricardo Cabezas-Pérez, Mónica Losada-Barragán, Karina Vargas-Sánchez, Rodrigo E. González-Reyes · 2022 · International Journal of Molecular Sciences
  52. The Effects of a Mixture of Cadmium, Lead, and Mercury on Metabolic Syndrome and Its Components, as well as Cognitive Impairment: Genes, MicroRNAs, Transcription Factors, and Sponge Relationships
    Hai Duc Nguyen, Min‐Sun Kim · 2022 · Biological Trace Element Research
  53. Network pharmacology and bioinformatics approach reveals the therapeutic mechanism of action of curcumin in Alzheimer disease
    Deepanshi Vijh, Md Ali Imam, Mohd Maksuf Ul Haque, Subhajit Das, Asimul Islam, Md. Zubbair Malik · 2023 · Metabolic Brain Disease
  54. Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases
    Diana Boraschi, Paola Italiani, Paola Migliorini, Paola Bossù · 2023 · Frontiers in Immunology
  55. Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer's disease
    Sodiq Fakorede, Olubodun Michael Lateef, Wilson Amemewon Garuba, Priscilla Onaopemipo Akosile, Deborah Ave Okon, Abdullahi Tunde Aborode · 2025 · Journal of Alzheimer s Disease Reports
  56. Essential oil of Schisandra chinensis ameliorates cognitive decline in mice by alleviating inflammation
    Mengjie Xu, Xiaoying Zhang, Fangyi Ren, Tingxu Yan, Bo Wu, BI Kai-shun, Wenchuan Bi, Ying Jia · 2019 · Food & Function
  57. YKL-40 and neuron-specific enolase in neurodegeneration and neuroinflammation
    Valentin Dichev, Maria Kazakova, Victoria Stepan Sarafian · 2020 · Reviews in the Neurosciences
  58. Systemic inflammation as a moderator between sleep and incident dementia
    Andrée‐Ann Baril, Alexa Beiser, Susan S Redline, Emer R. McGrath, Hugo Javier Aparicio, Daniel J. Gottlieb, Sudha S. Seshadri, Matthew Paul Pase, Jayandra Jung Himali · 2020 · SLEEP
  59. Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-β Plaque Deposition in the App NL – G – F Mouse Model of Alzheimer’s Disease
    Mona Sohrabi, Heidi L. Pecoraro, Colin Kelly Combs · 2021 · Journal of Alzheimer s Disease
  60. Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanisms
    Albert Garcia‐Romeu, Sean Darcy, Hillary Jackson, Toni White, Paul B. Rosenberg · 2021 · Current topics in behavioral neurosciences
  61. Mangostanaxanthone IV Ameliorates Streptozotocin-Induced Neuro-Inflammation, Amyloid Deposition, and Tau Hyperphosphorylation via Modulating PI3K/Akt/GSK-3β Pathway
    Hossam M. Abdallah, Nesrine S. El Sayed, Alaa Sirwi, Sabrin R. M. Ibrahim, Gamal Abdallah Mohamed, Nora O. Abdel Rasheed · 2021 · Biology
  62. Carbamate-based N-Substituted tryptamine derivatives as novel pleiotropic molecules for Alzheimer's disease
    Honghua Zhang, Yuying Wang, Dan Liu, Junfang Li, Yiyue Feng, Ying‐Mei Lu, Gaofeng Yin, Li Zhao, Tao Shi, Zhen Wang · 2022 · Bioorganic Chemistry
  63. Donepezil halts acetic acid-induced experimental colitis in rats and its associated cognitive impairment through regulating inflammatory/oxidative/apoptotic cascades: An add-on to its anti-dementia activity
    Eman Maher Elbaz, Reham M. Essam, Kawkab A. Ahmed, Maheera H. Safwat · 2023 · International Immunopharmacology
  64. Importance of physical and functional properties of foods targeted to seniors
    J. Grochowicz, Anna Fabisiak, Adam Ekielski · 2021 · Journal of Future Foods
  65. Advanced nano delivery system for stem cell therapy for Alzheimer's disease
    Yilong Pan, Long Li, Ning Cao, Jun Liao, Huiyue Chen, Meng Zhang · 2024 · Biomaterials
  66. Age-Related Cognitive Decline and Dementia: Interface of Microbiome–Immune–Neuronal Interactions
    Santosh Kumar Prajapati, Shalini Jain, Hariom Yadav · 2025 · The Journals of Gerontology Series A
  67. The therapeutic potential of galectin-1 and galectin-3 in the treatment of neurodegenerative diseases
    Eleazar Ramírez Hernández, Claudia Sánchez-Maldonado, Miguel Ángel Mayoral Chávez, Luis Fernando Hernández-Zimbrón, Aleidy Patricio-Martínez, Edgar Zenteno, Ilhuicamina Daniel Limón · 2020 · Expert Review of Neurotherapeutics
  68. Enzyme-digested Colla Corii Asini (E’jiao) prevents hydrogen peroxide-induced cell death and accelerates amyloid beta clearance in neuronal-like PC12 cells
    Li Xiao, Feng Liao, Ryoji Ide, Tetsuro Horie, Yumei Fan, Chikako Saiki, Nobuhiko Miwa · 2020 · Neural Regeneration Research
  69. Neuroprotective effects of the aerial parts of Polygala tenuifolia Willd extract on scopolamine‑induced learning and memory impairments in mice
    Xiao Dan Wang, Dian Zhang, Weihao Song, Cai Cheng, Zihao Zhou, Qi Fu, Xingrong Yan, Yanjun Cao, Min‐Feng Fang · 2020 · Biomedical Reports
  70. iPSC-Derived Microglia for Modeling Human-Specific DAMP and PAMP Responses in the Context of Alzheimer’s Disease
    Ivanna Ihnatovych, Barbara G. Birkaya, Emily Notari, Kinga Szigeti · 2020 · International Journal of Molecular Sciences
  71. Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
    Maja Przybyłowska, Krystyna Dzierzbicka, Szymon Kowalski, Klaudia Chmielewska, Iwona Inkielewicz‐Stępniak · 2020 · Current Neuropharmacology
  72. Severe Spinal Cord Injury in Rats Induces Chronic Changes in the Spinal Cord and Cerebral Cortex Metabolism, Adjusted by Thiamine That Improves Locomotor Performance
    Alexandra I. Boyko, Polina Tsepkova, Vasily A. Aleshin, Artem V. Artiukhov, Garik V. Mkrtchyan, Alexander L. Ksenofontov, Lyudmila A. Baratova, Sergey I. Ryabov, Anastasia V. Graf, Victoria I. Bunik · 2021 · Frontiers in Molecular Neuroscience
  73. The Potential Role of Inflammation in Modulating Endogenous Hippocampal Neurogenesis After Spinal Cord Injury
    Arthur Sefiani, Cédric G. Geoffroy · 2021 · Frontiers in Neuroscience
  74. Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
    María Gordillo‐Marañón, Magdalena Zwierzyna, Pimphen Charoen, Fotios Drenos, Sandesh Chopade, Tina Shah, Jorgen Engmann, Juan Pablo Casas, Nishi Chaturvedi, Olia Papacosta et al. · 2021 · Nature Communications
  75. Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms
    Chiara Villa, Eleonora Rivellini, Marialuisa Lavitrano, Romina Combi · 2022 · Journal of Personalized Medicine
  76. Association between risk of obstructive sleep apnea, inflammation and cognition after 45 years old in the Canadian Longitudinal Study on Aging
    Cynthia Thompson, Julie Legault, Grégory Moullec, Marie‐Ève Martineau‐Dussault, Marc Baltzan, Nathan E. Cross, Thien Thanh Dang‐Vu, Nicole J Gervais, Gillian Einstein, Patrick J. Hanly et al. · 2022 · Sleep Medicine
  77. Syndecan-3 as a Novel Biomarker in Alzheimer’s Disease
    Anett Hudák, Annamária Letoha, Csaba Vízler, Tamás Letoha · 2022 · International Journal of Molecular Sciences
  78. Inhibition of Pro-Inflammatory Cytokine Secretion by Polyphenol-Rich Extracts in Macrophages via NF-κB Pathway
    Katarzyna Chojnacka, Urszula Lewandowska · 2022 · Food Reviews International
  79. α7nAChR activation protects against oxidative stress, neuroinflammation and central insulin resistance in ICV-STZ induced sporadic Alzheimer's disease
    P. Yamini, R. S. Ray, Sonal Yadav, Jatinder Dhaliwal, Manisha Yadav, Kanthi Kiran Kondepudi, Kanwaljit Chopra · 2022 · Pharmacology Biochemistry and Behavior
  80. Recent advances of small molecule JNK3 inhibitors for Alzheimer’s disease
    Pengxia Qin, Yingying Ran, Yujing Liu, Chao Wei, Xiaoyi Luan, Haoqian Niu, Jie Peng, Jie Sun, Jingde Wu · 2022 · Bioorganic Chemistry
  81. Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer’s Disease Aetiopathogenesis in Men
    Pablo García‐González, Itziar de Rojas, Sonia Moreno–Grau, Laura Montrreal, Raquel Puerta, Emilio Alarcón‐Martín, Inés Quintela, Adela Orellana, Víctor Andrade, Pamela V. Martino Adami et al. · 2023 · International Journal of Molecular Sciences
  82. Three-dimensional human neural culture on a chip recapitulating neuroinflammation and neurodegeneration
    You Jung Kang, Yen Ngoc Diep, Minh Tran, Van Thi Ai Tran, Ghuncha Ambrin, Huyen Thi Ngo, Hansang Cho · 2023 · Nature Protocols
  83. Association between thyroid function and Alzheimer's disease: A systematic review
    Figueroa, Paulina Belén Sepulveda, Ferreira, Ana Flávia Fernandes, Britto, Luiz Roberto, Doussoulin, Arlette Patricia, Torrão, Andréa da Silva · 2021 · Metabolic Brain Disease
  84. Alzheimer Disease Pathology and Neurodegeneration in Midlife Obesity: A Pilot Study
    Mahsa Dolatshahi, Paul K. Commean, Farzaneh Rahmani, Jingxia Liu, LaKisha Lloyd, Caitlyn Nguyen, Nancy Hantler, Maria J. Ly, Gary Z. Yu, Joseph E. Ippolito et al. · 2023 · Aging and Disease
  85. Emerging Alzheimer’s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions
    Nour S. Tobeh, Kimberley D. Bruce · 2023 · Frontiers in Aging Neuroscience
  86. New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases
    Chengfeng Wang, Yu Cui, Tong Xu, Yu Zhou, Ting Wang, Ting Wang · 2023 · Biochemical Pharmacology
  87. Modifiable risk factors for mild cognitive impairment among cognitively normal community-dwelling older adults: A systematic review and meta-analysis
    Christo Y.Y. He, Zhixing Zhou, Mandy M. P. Kan, Dorothy H.Y. Chan, Athena C.T. Wong, Kenny H.Y. Mok, Freddy Man Hin Lam, Sam C. C. Chan, Chelsia K.C. Cheung, Michael.K.C. Yeung et al. · 2024 · Ageing Research Reviews
  88. Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer’s disease
    Nuanyi Liang, Kwangsik T. Nho, John W. I. Newman, Matthias Arnold, Kevin Huynh, Peter J. Meikle, Kamil Borkowski, Rima Kaddurah‐Daouk, Alexandra Kueider‐Paisley, Pudugramam Murali Doraiswamy et al. · 2024 · Scientific Reports
  89. The Benzoxazole Heterocycle: A Comprehensive Review of the Most Recent Medicinal Chemistry Developments of Antiproliferative, Brain-Penetrant, and Anti-inflammatory Agents
    Simona Di Martino, Maria De Rosa · 2024 · Topics in Current Chemistry
  90. A nasally administrated reactive oxygen species-responsive carrier-free gene delivery nanosystem for Alzheimer's disease combination therapy
    Yongke Chen, Xiaotong Yang, Jie Li, Hang Luo, Qianqian Huang, Wenqing Yang, Ting Lei, Yi Lü, Qiyong Gong, Hanmei Li et al. · 2025 · Journal of Controlled Release
  91. Molecular pathways and diagnosis in spatially resolved Alzheimer’s hippocampal atlas
    Pan Wang, Lei Han, Lifang Wang, Quyuan Tao, Zhen Guo, Ting Luo, Youzhe He, Zhi Ping Xu, Jiayi Yu, Yuyang Liu et al. · 2025 · Neuron
  92. The Interplay of Inflammatory Processes and Cognition in Alcohol Use Disorders—A Systematic Review
    Violette Coppens, Manuel Morrens, Marianne Destoop, Geert Dom · 2019 · Frontiers in Psychiatry
  93. Caspase-6 Knockout in the 5xFAD Model of Alzheimer’s Disease Reveals Favorable Outcome on Memory and Neurological Hallmarks
    Ariel Angel, Rotem Volkman, Tabitha Grace Royal, Daniel Offen · 2020 · International Journal of Molecular Sciences
  94. M2b macrophage subset decrement as an indicator of cognitive function in Alzheimer's disease
    Sun‐Wung Hsieh, Ling‐Chun Huang, Yang‐Pei Chang, Chih‐Hsing Hung, Yuan‐Han Yang · 2020 · Psychiatry and Clinical Neurosciences
  95. The Viral Hypothesis in Alzheimer’s Disease: Novel Insights and Pathogen-Based Biomarkers
    Naughton, Sean X, Raval, Urdhva, Pasinetti, Giulio M. · 2020 · Journal of Personalized Medicine
  96. Inflammation in Alzheimer’s Disease: Do Sex and APOE Matter?
    Paula Duarte‐Guterman, on behalf of the Alzheimer’s Disease Neuroimaging Initiative, Arianne Albert, Amy M. Inkster, Cindy K. Barha, Liisa A.M. Galea · 2020 · Journal of Alzheimer s Disease
  97. Neuroprotective Effect of 2-Aminoethoxydiphenyl Borate (2-APB) in Amyloid β-Induced Memory Dysfunction: A Mechanistic Study
    Pavan Thapak, Pragyanshu Khare, Mahendra Bishnoi, Shyam Sunder Sharma · 2020 · Cellular and Molecular Neurobiology
  98. The role of P2X7R in neuroinflammation and implications in Alzheimer's disease
    Yi-He Chen, Rong-Rong Lin, Qing‐Qing Tao · 2021 · Life Sciences
  99. Brain Metabolism and Microglia Activation in Mild Cognitive Impairment: A Combined [18F]FDG and [11C]-(R)-PK11195 PET Study
    Giacomo Tondo, Cecilia Boccalini, Silvia Paola Caminiti, Luca Presotto, Massimo Filippi, Giuseppe Magnani, Giovanni Battista Frisoni, Sandro Iannaccone, Daniela Perani · 2021 · Journal of Alzheimer s Disease
  100. Extracellular Vesicles Released from Neprilysin Gene-Modified Human Umbilical Cord-Derived Mesenchymal Stem Cell Enhance Therapeutic Effects in an Alzheimer’s Disease Animal Model
    Hyeju Jeong, Ok Joon Kim, Seung‐Hun Oh, Sanghoon Lee, Han A. Reum Lee, Kee Ook Lee, Boo-Yong Lee, Nam Keun Kim · 2021 · Stem Cells International